Real‐world experience with mepolizumab: Does it deliver what it has promised?-Reference-Cited by-同舟云学术

Real‐world experience with mepolizumab: Does it deliver what it has promised?

Published:2020-04-14 Issue:6 Volume:50 Page:687-695
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Schleich Florence¹²^ORCID,Graff Sophie¹²^ORCID,Nekoee Haleh³,Moermans Catherine¹²^ORCID,Henket Monique¹²,Sanchez Carole¹²,Paulus Virginie¹²,Guissard Françoise¹²,Donneau Anne‐Françoise³,Louis Renaud¹²

Affiliation:

1. Department of Pulmonary Medicine CHU Sart‐Tilman Liege Belgium

2. I³ GIGA Research Group University of Liege Liege Belgium

3. Medical Informatics and Biostatistics University of Liege Liege Belgium

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.13601

Reference27 articles.

1. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma

2. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR)

3. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

4. Non-eosinophilic cor ticosteroid unresponsive asthma

5. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases;International Journal of Molecular Sciences;2024-02-05

2. When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report;Journal of Medical Case Reports;2024-01-31

3. Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophiliaversusexhaled nitric oxide fraction – PROMISE;ERJ Open Research;2023-11

4. Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy;The Journal of Allergy and Clinical Immunology: In Practice;2023-09

5. Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion;ERJ Open Research;2023-09